Download FREE Report Sample
Download Free sampleStromal vascular fraction skin treatment is a type of stem cell therapy based on isolation of adipose tissue during liposuction or lipo-aspiration procedures of patient?s own body.
Stromal Vascular Fraction Market contains market size and forecasts of Stromal Vascular Fraction in Global, including the following market information:
Global Stromal Vascular Fraction Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Stromal Vascular Fraction market was valued at 82 million in 2021 and is projected to reach US$ 103.9 million by 2028, at a CAGR of 3.5% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
SVF Isolation Products Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Stromal Vascular Fraction include Cytori Therapeutics, GE Healthcare, Ingeneron, Medikan International, Tissue Genesis, Genesis Biosystems, Human Med, IntelliCell BioSciences and LifeCell. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Stromal Vascular Fraction companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Stromal Vascular Fraction Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Stromal Vascular Fraction Market Segment Percentages, by Type, 2021 (%)
SVF Isolation Products
Enzymatic Isolation
Non-enzymatic Isolation
Automated POC Devices
SVF Aspirate Purification Products
SVF Transfer Products
Global Stromal Vascular Fraction Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Stromal Vascular Fraction Market Segment Percentages, by Application, 2021 (%)
Hospitals
Specialty Clinics
Stem Cell Banks/Laboratories
Others
Global Stromal Vascular Fraction Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Stromal Vascular Fraction Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Stromal Vascular Fraction revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Stromal Vascular Fraction revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cytori Therapeutics
GE Healthcare
Ingeneron
Medikan International
Tissue Genesis
Genesis Biosystems
Human Med
IntelliCell BioSciences
LifeCell
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
